Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to clarify efficacy and toxicity of daily low-dose Nedaplatin
(CDGP) and continuous infusion of 5-FU combined with radiation in patients with esophageal
squamous cell carcinoma.